End-to-End Clinical Trial & CRO Services in Brazil
Trusted CRO partner providing clinical development, data management, regulatory, and safety services across all trial phases.
Zenovel provides comprehensive CRO support in Brazil, helping pharma and biotech companies navigate the full clinical trial journey with confidence. From study planning and data handling to regulatory compliance and safety monitoring, Zenovel ensures seamless, efficient, and high-quality execution at every stage.
Explore our services below to see how we can support your clinical development needs.
Good Clinical Practice (GCP) Services in Brazil for Clinical Trial Compliance
Your GCP Compliance Partner for Successful Clinical Trials in Brazil.
In Brazil, compliance with Good Clinical Practice (GCP) is essential for the success of clinical trials. Pharmaceutical and biotech companies must adhere to ICH-GCP guidelines and ANVISA regulations to ensure patient safety, ethical conduct, and data integrity.
Here, Zenovel acts as a partner and offers GCP CRO services in Brazil:
- Clinical trial monitoring & risk‑based monitoring (RBM)
- GCP audits & inspection readiness support
- Investigator site compliance & sponsor oversight
- Clinical quality assurance systems & regulatory consulting
Our ICH GCP services in Brazil: our team assists sponsors in mitigating compliance risks, ensuring solid documentation, and expediting trial timelines amid heightened ANVISA scrutiny.
Computer System Validation (CSV) Services for GCP Compliance in Brazil
We offer CSV Expertise for GCP Compliance and Audit‑Ready Clinical Systems in Brazil.
Validated computerized systems are crucial for GCP compliance in Brazilian clinical trials, ensuring data integrity, audit trail transparency, and adherence to ICH-GCP and ANVISA standards.
Zenovel offers specialized CSV (Computer System Validation) services in Brazil, catering to pharmaceutical, biotech, and CRO (Contract Research Organization) sectors.
Our CSV services in Brazil include the following:
- Validation of EDC, CTMS, and clinical databases
- GAMP 5‑aligned, risk‑based validation strategies
- GCP‑compliant system validation & audit trail compliance
- Full lifecycle validation for inspection readiness
Our CSV CRO services in Brazil assist in mitigating compliance risks and ensuring reliable clinical data management amidst growing regulatory scrutiny.
At Zenovel, our team ensures that clinical systems are fully validated and ready for inspection.
GCP Audit Services for Clinical Trial Quality & Compliance in Brazil
With Zenovel, ensure your GCP Audit Expertise for Clinical Trial Quality and Compliance in Brazil.
GCP audits are crucial for maintaining trial quality, ethical standards, data integrity, and regulatory compliance for clinical trials in Brazil, aligning with ICH-GCP and ANVISA standards.
Zenovel offers comprehensive GCP audit services in Brazil for maintaining clinical trial quality and compliance:
Site‑level compliance audits & documentation accuracy checks
Sponsor, CRO, and investigator site audits
CAPA assessments & risk‑based evaluations
Inspection readiness & GCP compliance gap analysis
We assist your organizations in enhancing clinical quality systems, minimizing compliance risks, and ensuring they are fully prepared for audits.
CRO Setup & Upgradation Services for Clinical Excellence in Brazil
We advance CRO Setup & Upgradation by our solutions for Brazil’s Clinical Research Industry
Building or upgrading a Clinical Research Organization (CRO) in Brazil requires compliance with regulatory standards, operational effectiveness, and alignment with ICH-GCP and ANVISA guidelines.
At Zenovel, we provide expert-driven GCP CRO services in Brazil designed to support end-to-end clinical trial operations.
- SOP development & clinical quality management systems
- Governance frameworks & risk‑based monitoring structures
- Process optimization & compliance strengthening for existing CROs
- Inspection‑ready, performance‑driven clinical operations
At Zenovel, we assist pharmaceutical and biotech companies in creating scalable, audit-ready CRO environments to achieve high-quality trial outcomes, transforming clinical operations.
Take the next step toward building a compliant and future-ready CRO in Brazil.
PK-Stat Review Services for Accurate Clinical Data Analysis in Brazil
We ensure your clinical data is ready for regulatory approval through our PK-Stat Review services.
Accurate pharmacokinetic and statistical analysis is essential for reliable clinical trial outcomes and ANVISA approval. Our PK‑Stat review services ensure precise data interpretation and regulatory readiness.
Zenovel provides specialized PK‑Stat review services in Brazil:
- Validation of pharmacokinetic and statistical data
- Compliance with ANVISA and global regulatory expectations
- Exposure‑response assessment & clinical endpoint strengthening
- PK/PD statistical review, modeling support & submission assistance
We help sponsors and biotech companies reduce risk, accelerate timelines, and ensure every dataset is scientifically sound and regulatory‑ready.
Ensure your clinical data is accurate, compliant, and inspection‑ready with Zenovel.
Pre-Inspection Readiness Services for GCP Compliance in Brazil
We assist in GCP Inspection Readiness and assure Compliance Confidence in Brazil
Regulatory inspections are a critical milestone. Inadequate preparation can lead to findings, delays, or study setbacks. Our pre‑inspection readiness services in Brazil ensure your clinical trials are fully compliant and inspection‑ready at all times.
Zenovel provides expert GCP pre‑inspection readiness in Brazil:
- Gap analysis of documentation, processes & trial conduct
- Audit trail & CAPA system evaluation
- GCP audit preparation & mock inspection support
- Continuous compliance improvement for ANVISA alignment
We help sponsors, CROs, and sites from Brazil strengthen quality systems, reduce compliance risks, and face inspections with confidence.
Be fully prepared before the inspection arrives
Risk‑Based Monitoring (RBM) Services for Efficient Clinical Trials in Brazil
We ensure your clinical trial excellence in Brazil by our robust risk-based monitoring
Efficient clinical trial oversight is essential for data integrity, patient safety, and ANVISA compliance. Our risk‑based monitoring (RBM) services in Brazil optimize trial performance, reduce operational burden, and improve decision‑making.
Zenovel provides expert RBM services in Brazil:
- Proactive, data‑driven risk identification
- Centralized & remote monitoring capabilities
- GCP‑compliant RBM strategies for sponsor oversight
- Real‑time data review & site performance assessment
We help organizations detect deviations early, allocate resources smarter, and enhance trial visibility while maintaining full regulatory alignment.
Improve clinical trial efficiency with smarter, risk‑based monitoring in Brazil.
Sponsor Oversight Services for Clinical Trial Governance in Brazil
We ensure ethical conduct, trial quality, and regulatory compliance by a set of sponsor oversight vigils.
Strong sponsor oversight ensures ethical conduct, regulatory compliance, and high‑quality trial execution. Our services of sponsor oversight in Brazil specifically strengthen governance frameworks, improve transparency, and align with ICH‑GCP and ANVISA requirements.
Zenovel provides expert sponsor oversight in Brazil:
- Continuous control over study conduct, sites & vendors
- Proactive risk management & compliance monitoring
- CAPA oversight, audit trail review & governance frameworks
- Audit readiness & clinical operations oversight
We help pharmaceutical and biotech companies from Brazil to maintain accountability, data integrity, and regulatory confidence across all trial phases.
Ensure complete control, compliance, and confidence in your clinical trials.
Good Manufacturing Practice (GMP) Services for Pharma Compliance in Brazil
We ensure excellent product quality, patient safety, data integrity, and regulatory approval by our in-house GMP services
GMP compliance is essential for product quality, patient safety, and ANVISA approval. Our GMP services in Brazil help pharmaceutical companies meet ANVISA and global regulatory standards with confidence.
Zenovel provides end‑to‑end GMP services in Brazil:
- GMP audits & quality system assessments
- Inspection readiness & CAPA implementation
- GMP validation services for processes and systems
- Quality management system (QMS) strengthening
We help manufacturers from Brazil identify compliance gaps, improve operational efficiency, and maintain audit‑ready production systems.
Strengthen your pharmaceutical compliance with Zenovel.
GMP Audit Services for Manufacturing Quality Assurance in Brazil
We drive your regulatory confidence by our GMP audit support across Brazil
GMP audits are critical for maintaining product safety, regulatory approval, and manufacturing excellence. Our services evaluate and strengthen quality systems in alignment with ANVISA and global standards.
Zenovel provides comprehensive GMP audit services in Brazil:
- Assessment of production processes, facilities & quality controls
- GAP analysis & CAPA effectiveness evaluation
- Deviation handling & quality management system (QMS) review
- Inspection readiness & risk‑based audit preparation
We help pharmaceutical manufacturers reduce compliance risks, ensure traceability, and maintain audit‑ready operations.
Strengthen your manufacturing quality with Zenovel.
Pharma Plant Setup & Upgradation Services (GMP‑Compliant) in Brazil
We Transform Pharma Facilities to Global GMP Standards in Brazil.
Setting up or upgrading a pharmaceutical manufacturing facility demands precision, regulatory alignment, and strict GMP adherence. Our services GMP compliant services across Brazil help you build fully compliant, inspection‑ready facilities aligned with ANVISA and global standards.
Zenovel provides end‑to‑end GMP‑compliant plant solutions in Brazil:
- Facility layout, cleanroom planning & utility qualification
- Quality system integration & validation protocols
- Infrastructure modernization & production workflow optimization
- Risk‑based assessments & CAPA system integration
We support both new plant setup and existing facility upgradation with minimal operational disruption.
Build a future‑ready, GMP‑compliant manufacturing facility in Brazil with Zenovel.
Pre‑Inspection Readiness Services for GMP Compliance in Brazil
Regulating Excellence through our GMP Pre-Inspection Readiness Services
Regulatory inspections are essential for successful pharmaceutical manufacturing, as documentation and process gaps can cause delays and compliance risks. Our GMP pre-inspection readiness services in Brazil ensure facilities are compliant and ready for inspections, aligning with Good Manufacturing Practice (GMP) and ANVISA standards.
- GMP audit readiness & pharmaceutical inspection readiness
- Detailed gap analysis of manufacturing systems, documentation & quality processes
- CAPA effectiveness evaluation, batch record compliance & audit trail integrity
- Mock inspections simulating real ANVISA scrutiny
Our GMP compliance readiness services in Brazil enhance your quality management system and operational control, preparing teams for inspections. Selecting the right partner is crucial to mitigating compliance risks and maintaining smooth manufacturing operations. We offer expert solutions based on regulatory knowledge and global compliance standards.
Clinical & Scientific Expert Services for Drug Development in Brazil
Advancing Drug Development with Clinical & Scientific Expertise in Brazil
Successful drug development demands scientific strategy, clinical precision, and regulatory alignment. Our expert services support pharmaceutical and biotech organizations in accelerating development while ensuring scientific validity and ANVISA compliance.
Zenovel provides specialized clinical and scientific expertise in Brazil:
- Clinical strategy, study design & protocol development
- PK/PD evaluation & translational strategy support
- Endpoint selection, clinical trial optimization & evidence generation
- Regulatory alignment with ICH‑GCP & ANVISA
We help reduce development risks, improve study efficiency, and enhance regulatory success from early‑phase planning through late‑stage trials.
Accelerate your drug development with Zenovel.
Medical & Scientific Writing Services for Regulatory Success in Brazil
Empowering Regulatory Success Through Expert Medical Writing in Brazil
High‑quality documentation is the backbone of regulatory submissions and clinical development. Our medical writing services across Brazil deliver accurate, compliant, and scientifically robust documents aligned with ICH‑GCP and ANVISA standards.
Zenovel provides expert medical and scientific writing in Brazil:
- Clinical study reports (CSR), protocols & investigator brochures
- Regulatory submission documents & eCTD module preparation
- Pharmacovigilance documentation & clinical summaries
- Audit‑ready, clear, and consistent scientific writing
We transform complex clinical data into submission‑ready documents, reducing review cycles and accelerating approvals.
Accelerate your regulatory success with Zenovel.
Preclinical Support Services for Early-Stage Drug Development in Brazil
Accelerating Early-Stage Drug Development with Preclinical Expertise in Brazil.
Strong preclinical evidence is the foundation of successful drug development. Our preclinical support services in Brazil help pharmaceutical and biotech companies generate reliable, regulatory‑ready data for early‑stage programs.
Zenovel provides expert preclinical support in Brazil:
- In vitro & in vivo study design
- Toxicology, pharmacology & ADME/PK analysis
- IND‑enabling studies & safety pharmacology
- Translational research to bridge discovery to clinic
We align with ICH‑GCP, GLP, and global standards, reducing risk and improving decision‑making.
Accelerate your early drug development with Zenovel across Brazil.
Regulatory Affairs & Compliance Services for Global Submissions in Brazil
We offer Expert Regulatory Affairs Support for Successful Global Submissions in Brazil
Navigating global regulatory pathways requires precision, scientific expertise, and deep compliance knowledge. Our regulatory affairs services help pharmaceutical and biotech companies achieve successful approvals across multiple international markets.
Zenovel provides expert regulatory support in Brazil:
- Dossier preparation & submission strategy (ANVISA & global)
- eCTD compilation & CTD preparation
- Regulatory gap analysis & lifecycle management
- Post‑submission support & compliance optimization
We reduce approval timelines, minimize compliance risks, and ensure your submissions are strategically positioned for success.
Accelerate your global approvals with Zenovel.
Dossier Due Diligence Services for Regulatory Accuracy in Brazil
We offer Brazil-Focused Dossier Due Diligence for Regulatory Excellence
Regulatory submissions demand absolute accuracy, consistency, and compliance. Our dossier due diligence services reduce the risk of submission delays or rejections by ensuring your documents meet global standards.
Zenovel provides expert dossier review in Brazil:
- Detailed review of CTD & eCTD submissions
- Gap analysis, consistency checks & compliance verification
- Cross‑module alignment & data integrity assessment
- Audit‑ready, submission‑compliant documentation
We help organizations strengthen submission quality and improve approval success rates.
Ensure your regulatory submissions are accurate, compliant, and approval‑ready with Zenovel.
eCTD Compilation Services for Global Regulatory Submissions in Brazil
We accelerate your Global Regulatory Approvals with eCTD Excellence
Accurate, structured, and compliant eCTD submissions are critical for global drug approval. Our compilation services available in Brazil ensure your dossiers meet ANVISA and international standards with precision.
Zenovel provides expert eCTD support in Brazil:
- End‑to‑end dossier preparation, validation & publishing
- CTD conversion & document structuring
- Submission lifecycle management & compliance checking
- Audit‑ready, error‑free global submissions
We help pharmaceutical and biotech companies across Brazil reduce submission delays and improve approval success rates.
Accelerate your global approvals with Zenovel.
Environmental Risk Assessment Services for Regulatory Compliance in Brazil
We Supports Regulatory Compliance Through Environmental Risk Assessment in Brazil
Environmental safety is critical for pharmaceutical approval and sustainable development. Our risk assessment services in Brazil help you meet ANVISA and global environmental guidelines with confidence.
Zenovel provides expert environmental compliance support in Brazil:
- Chemical exposure & waste impact evaluation
- Environmental safety risk identification & mitigation
- Regulatory documentation for submissions
- Sustainable, compliant development pathways
We help pharmaceutical and biotech companies minimize risk, ensure compliance, and meet environmental responsibilities across the product lifecycle.
Ensure your operations are safe, compliant, and environmentally responsible with Zenovel.
EU QP Support Services for Batch Release Compliance in Brazil
We offer Reliable EU QP Services for Efficient and Compliant Market Release across Brazil
Compliant batch release for EU markets requires strict GMP adherence and Qualified Person (QP) oversight. Our EU QP support services in Brazil help pharmaceutical manufacturers achieve seamless batch certification and regulatory acceptance for Europe.
Zenovel provides expert QP support in Brazil:
- Batch review & documentation verification
- GMP compliance assessment per EU Annex 16
- Deviation, CAPA & quality documentation review
- Audit‑ready manufacturing and release processes
We help exporters reduce regulatory risks, ensure traceability, and accelerate EU market access.
Ensure compliant EU batch release with Zenovel.
Regulatory Gap Analysis Services for Compliance Readiness in Brazil
We assist you with Regulatory Gap Analysis and Inspection Readiness in Brazil.
Identifying compliance gaps early is essential for effective clinical development, manufacturing, and obtaining ANVISA approvals. Our regulatory gap analysis services assist in fortifying systems before inspections.
Zenovel offers detailed gap analysis services tailored for the pharmaceutical industry in Brazil, addressing regulatory compliance and market needs.
- Evaluation of documentation, processes & quality systems
- Alignment with GCP, GMP, and global regulatory standards
- Assessment of SOPs, audit trails, CAPA systems & regulatory files
- Clear, actionable remediation strategies for inspection readiness
Zenovel assists sponsors, CROs, and manufacturers in minimizing approval delays and compliance risks through evidence-based, structured assessments, fostering regulatory confidence.
Accelerate your global approvals with expert regulatory support.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
